Botanix Pharmaceuticals Ltd News

Botanix Pharmaceuticals Ltd: Annual General Meeting - Chairman's Address

Nov 4 06:55

Botanix Pharmaceuticals Ltd: Botanix Staff Update and AGM Notice of Meeting

Oct 3 07:11

Botanix Pharmaceuticals Ltd: Appendix 4G and Corporate Governance Statement

Sep 19 14:29

Botanix Pharmaceuticals Ltd: Botanix Commercial Day Webinar - Registration Information

Sep 11 10:00

Botanix Pharmaceuticals Ltd: 2024 Annual General Meeting - Key Dates

Sep 10 08:25

Botanix Pharmaceuticals Ltd: June 2024 Quarterly Activities Report and Appendix 4C

Jul 31 07:19

Botanix Pharmaceuticals Ltd: Issue of Securities

Jul 18 16:50

Botanix Pharmaceuticals Ltd: FDA Approves Sofdra

Jun 20 07:06

Botanix Pharmaceuticals Ltd: Trading Halt

Jun 19 07:14

Botanix Pharmaceuticals Ltd: Change of Registered Office

Jun 14 10:07

Botanix Pharmaceuticals Ltd: Final Sofdra Labelling Discussions with FDA

Jun 12 06:34

Botanix Pharmaceuticals Ltd: Change of Auditor

Jun 5 15:45

Botanix Pharmaceuticals Ltd: Botanix Webinar - Registration Information

May 7 07:28

Botanix Pharmaceuticals Ltd: March 2024 Quarterly Activities Report and Appendix 4C

Apr 30 12:09

Botanix Pharmaceuticals Ltd: Botanix Included in the All Ordinaries Index

Apr 15 06:32

Botanix Pharmaceuticals Ltd: Botanix Appoints Graeme Morissey CFO

Mar 26 06:39

Botanix Pharmaceuticals Ltd: December 2023 Quarterly Activities Report and Appendix 4C

Jan 31 06:30

Botanix Pharmaceuticals Ltd: NDA Resubmission Accepted and Approval Date Confirmed

Jan 22 05:29

Botanix Pharmaceuticals Ltd: Botanix Resubmission of NDA for Sofdra Completed

Dec 21, 2023 06:11

Botanix Pharmaceuticals Ltd: Successful Completion of Human Factors Study

Dec 14, 2023 06:10